BMO Capital lowered the firm’s price target on Equifax (EFX) to $245 from $251 and keeps a Market Perform rating on the shares. The company reported a solid quarter bolstered by top-line strength in mortgage, and the management is very focused on New Product Initiatives across segments, which should help drive competitive differentiation and organic growth, the analyst tells investors in a research note. BMO is raising its FY25 estimates on the mortgage strength, though modestly lowering its 2026 and 2027 estimates on more measured out-year mortgage volume growth, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EFX:
- Equifax price target lowered to $253 from $295 at Stifel
- Equifax Reports Strong Q3 Results, Raises Guidance
- Morning Movers: General Motors and RTX higher following Q3 reports
- Equifax’s Strong Q3 Performance and Raised Outlook Justify Buy Rating
- Equifax sees Q4 adjusted EPS $1.98-$2.08, consensus $2.08